These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30181802)

  • 21. Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
    Shi KQ; Cai YJ; Lin Z; Dong JZ; Wu JM; Wang XD; Song M; Wang YQ; Chen YP
    J Gastroenterol Hepatol; 2017 Feb; 32(2):497-505. PubMed ID: 27490495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
    Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
    World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
    Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
    Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients.
    Shi H; Wang XH; Gu JW; Guo GL
    Cancer Manag Res; 2019; 11():10827-10839. PubMed ID: 31920392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy.
    Lai J; Wang H; Peng J; Chen P; Pan Z
    Cancer Manag Res; 2018; 10():2347-2356. PubMed ID: 30122984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.
    Wan G; Gao F; Chen J; Li Y; Geng M; Sun L; Liu Y; Liu H; Yang X; Wang R; Feng Y; Wang X
    BMC Cancer; 2017 Jan; 17(1):91. PubMed ID: 28143427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection.
    Chen S; Li X; Lv H; Wen X; Ding Q; Xue N; Su H; Chen H
    Int J Biol Sci; 2018; 14(13):1813-1821. PubMed ID: 30443185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
    Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
    J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Overall Survival After Curative Colectomy in a Chinese Colon Cancer Population.
    Liu M; Qu H; Bu Z; Chen D; Jiang B; Cui M; Xing J; Yang H; Wang Z; Di J; Chen L; Zhang C; Yao Z; Zhang N; Tan F; Gu J; Li Z; Su X
    Ann Surg Oncol; 2015 Nov; 22(12):3881-7. PubMed ID: 25963477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel prognostic model to predict OS and DFS of stage II/III gastric adenocarcinoma patients in China.
    Li J; Liang H; Xue X; Guo C; Jiao P; Sui X; Qiu H
    Heliyon; 2022 Dec; 8(12):e12403. PubMed ID: 36619400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients.
    Wang Y; Yang Y; Chen Z; Zhu T; Wu J; Su F; Deng H
    Ann Transl Med; 2019 Oct; 7(20):537. PubMed ID: 31807519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
    Ma T; Liu XY; Cai SL; Zhang J
    Front Cell Dev Biol; 2024; 12():1417366. PubMed ID: 39286481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.
    Guo LW; Jiang LM; Gong Y; Zhang HH; Li XG; He M; Sun WL; Ling H; Hu X
    Cancer Manag Res; 2018; 10():5881-5894. PubMed ID: 30510456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Nomogram for Prediction of Overall Survival in Patients with Node-negative Gallbladder Cancer.
    Chen M; Cao J; Zhang B; Pan L; Cai X
    J Cancer; 2019; 10(14):3246-3252. PubMed ID: 31289596
    [No Abstract]   [Full Text] [Related]  

  • 38. Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer.
    Mo S; Zhou Z; Li Y; Hu X; Ma X; Zhang L; Cai S; Peng J
    Cancer Cell Int; 2020; 20():285. PubMed ID: 32655317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram for Predicting Overall Survival and Assessing the Survival Benefit of Adjuvant Treatment in pT1-2N0M0 Triple-Negative Breast Cancer: A Surveillance, Epidemiology, and End Results-Based Study.
    Mao Q; Liu S; Lv M; Sun Y; Zhang C; Li L
    Front Oncol; 2021; 11():663621. PubMed ID: 35284333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery.
    Lin WX; Xie YN; Chen YK; Cai JH; Zou J; Zheng JH; Liu YY; Li ZY; Chen YX
    World J Clin Cases; 2022 Nov; 10(31):11338-11348. PubMed ID: 36387832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.